Now showing items 1-3 of 3

    • Assessment of the impact of the scanner-related factors on brain morphometry analysis with Brainvisa 

      Shokouhi, Mahsa; Barnes, Anna; Suckling, John; Moorhead, Thomas WJ; Brennan, David; Job, Dominic; Lymer, Katherine et al. (2011-12-21)
      Abstract Background Brain morphometry is extensively used in cross-sectional studies. However, the difference in the estimated values of the morphometric measures between patients and healthy subjects may be small and hence ...
    • Gait in Mild Alzheimer's Disease: Feasibility of Multi-Center Measurement in the Clinic and Home with Body-Worn Sensors: A Pilot Study. 

      Mc Ardle, Ríona; Morris, Rosie; Hickey, Aodhán; Del Din, Silvia; Koychev, Ivan; Gunn, Roger N; Lawson, Jennifer et al. (IOS Press, 2018-01)
      Gait is emerging as a potential diagnostic tool for cognitive decline. . The ‘Deep and Frequent Phenotyping for Experimental Medicine in Dementia Study’ (D&FP) is a multicentre feasibility study embedded in the United ...
    • PET Tau and Amyloid-β Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers. 

      Koychev, Ivan; Gunn, Roger N; Firouzian, Azadeh; Lawson, Jennifer; Zamboni, Giovanna; Ridha, Basil; Sahakian, Barbara Jacquelyn et al. (2017-01)
      BACKGROUND: Combining PET amyloid-β (Aβ) and tau imaging may be critical for tracking disease progression in Alzheimer's disease (AD). OBJECTIVE: We sought to characterize the relationship between Aβ and tau ligands as ...